Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF



GREY:IPHAF - Post by User

Comment by teeveeon Aug 04, 2010 10:07am
379 Views
Post# 17320113

RE: a few questions

RE: a few questionsAntoninus,
I doubt a takeover would happen. If ISA runs out of money, it simply goes bankrupt. Should that happen, and provided that Lux's partnering agreement would survive a bankruptcy, Lux could continue with another trial and Paladin could manufacture the drug for the trial. 
The only way I see ISA surviving is to lay off all staff, contract out drug manufacturing, move the office back to Foster's basement, and reduce salaries to a minimum. With G & A cut down to say $250K/year, ISA might survive another 2 years. 
<< Previous
Bullboard Posts
Next >>